Kami berpengalaman lebih dari 8 tahun dalam membantu mahasiswa S2 dan S3.
Hubungi sekarang juga - Kami mengerjakan tugas kuliah kedokteran
, makalah, paper, proposal skripsi, tugas akhir, dijamin orisinil dan otentik. 0812 1944 9060
Jurnal yang sering digunakan untuk penelitian kedokteran:
• Cancer
• Nutrition
& Cancer
• Journal
of Clinical Oncology
• Journal
of the National Cancer Institute
• Cancer
Research
• Integrative
Cancer Therapies
• American
Journal of Clinical Nutrition
• Alternative
Medicine Review
• International
Journal of Cancer
• Clinical
Pearls
• Anticancer
Research
• Townsend
Letter for Doctors & Their Patients
WEB RESOURCES
• www.oncanp.org
• www.aicr.org
• www.lifeovercancer.com
• www.cancerfacts.com
• www.nci.nih.gov
• www.cancernet.nci.nih.gov/clinpdq
• www.cancer.org American Cancer Society 1-800-ACS-2345
• www.cdc.gov.org/cancer
• www.bccancer.bc.ca
• www.y-me.org
• www.asco.org
• www.Medscape.com - oncology database
• www.inspirehealth.ca
• www.denvernaturopathic.com
• www.camresearch.net
• www.ncbi.nlm.nih.gov/PubMed/
• www.oncologystat.com
• www.epec.net
• www.lifeovercancer.com
Topic penelitian yang sedang menarik yang dapat anda gunakan
untuk diteliti:
Increased Expression of Human Macrophage Metalloelastase
(MMP-12) is Associated with the Invasion of Endometrial Adenocarcinoma, Yang,
Dong, Zhao,et al., Pathol Res Pract.
2007; 203 (7): 499-505. Epub 2007 Jun 14.
Role of Tumor-associated Macrophages in Tumor Progression
and Invasion, Mantovani, Schioppa, Porta, et al., Cancer Metastasis Rev. 2006;25( 3): 315-322.
Co-opting Macrophage Traits in Cancer Progression: A Consequence
of Tumor Cell Fusion? Pawelek, Chakraborty, Lazova, etr al., Contrib Microbiol.
2006; 13: 138-155.
Macrophages: Obligate Partners for Tumor Cell Migration,
Invasion, and Metastasis, Condeelis & Pollard, Cell 2006;124 (2): 263-266.
Prostate Cancer: Genes, Environment, Immunity and the Use of
Immunotherapy, Karan, Thrasher & Lubaroff, Prostate Cancer Prostatic
Dis. 2008; 11 (3): 230-236.
ER Alpha Status of
Disseminated Tumor Cells in Bone Marrow of Primary Breast Cancer Patients,
Fehm, Krawczyk, Solomayer, et al.,
Breast Cancer Res. 2008; 0 (5):
R76.
Resistance of Cancer Cells to Immune Recognition and
Killing, Lipinski & Egyud, Med. Hypoth. 2000; 54 (3): 456-460.
Molecular Biology of Macrophage Activation: A Pathway
Whereby Psychosocial Factors Can Potentially Affect Health, Adams, Psychosomat.
Med. 1994; 56: 316-327.
Disregulation in TH1 and TH2 Subsets of CD4+ T Cells in
Peripheral Blood of Colorectal Cancer Patients and Involvement in Cancer
Establishment and Progression, Pellegrini,
Berghella, Del Beato, et al., Cancer Immunol. Immunother. 1996; 42 (1):
1-8.
Th1/Th2 balance: The Hypothesis, Its Limitations, and
Implications for Health and Disease, Kidd, Altern. Med. Rev. 2003; 8(3):223-46
Effect of Major Dietary Modifications on the Immune System
in Patients with Breast Cancer, Garritson, Nikaein, Peters, et al., Cancer
Practice 1995; 3 (4): 239-246.
In vivo Effect of Ascorbic Acid on Enhancement of Human
Natural Killer Cell Activity, Vojdani
& Ghoneum, Nutr. Res.1993; 13:
753-754.
Enhancement of Human Natural Killer Cytotoxic Activity by
Vitamin C in Pure and Augmented Formulations, Vojdani & Namatalla, J. Nutr.
Environ. Med. 1997; 7 (3): 187-195.
Cancer-expanded Myeloid-derived Suppressor Cells Induce
Anergy of NK Cells Through Membrane-bound TGF-beta 1, Li, Han, Guo, et al., J.
Immunol. 2009; 182 (1): 240-249.
Signaling Mechanism(s) of Reactive Oxygen Species in
Epithelial-Mesenchymal Transition Reminiscent of Cancer Stem Cells in Tumor
Progression, Wang, Li & Sarkar, Curr. Stem Cell Res. Ther. 2010; 5 (1):
1-7.
SUGAR, INSULIN & IGF
Insulin and Cancer,
Boyd, Integr. Cancer. Ther.,
2003; 2 (4): 315-329.
Insulin-like Growth Factor 1 Tied to Prostate Cancer Risk,
Douglas, Medscape 487836 8/25/04.
Insulin-Like Growth Factor I Receptor Promotes Gastric
Cancer Adachi. et al., Gut 2005; 54: 591-600.
Diabetes, High Glucose Levels Linked to Cancer in Korean
Study, Jee, et al., JAMA 2005; 194-202
and editorial p. 235-236.
Diabetes Triples Risk of Liver Cancer, El-Serag, et al, Gut,
2005; 54: 533-539.
Elevated IGF-1 Linked to Raised Risk of Cancer in
Premenopausal Women, Shi, et al, Int. J. Cancer
2004; 111: 418-423.
High Dietary Glycemic Load May Increase Colorectal Cancer
Risk in Women, Higginbotham, et al, J.
Natl. Cancer Inst. 2004; 96: 229-233.
High Dietary Glycemic Load and Insulin Resistance Combine to
Increase Pancreatic Cancer Risk,
Michaud, et al., J. Natl. Cancer
Inst. 2002; 94: 1293-1300.
Controlling Hyperglycemia as an Adjunct to Cancer Therapy,
Krone & Ely, Integr. Cancer Ther.
2005; 4 (1): 25-31.
Fasting Insulin and Outcome in Early-Stage Breast
Cancer- Results of a Prospective Cohort
Study, Goodwin, et al, J. Clin. Oncol.,
2002; 20: 42-51.
Glycemic Index, Glycemic Load and Thyroid Cancer Risk, Randi, Ferraroni, Talamini, et al., Annals of
Oncol. 2008; 192: 380-383.
Green Tea Polyphenols Inhibit IGF-1 Signalling in Prostate
Cancer Model, Mukhtar, et al., Cancer Res.
2004; 64: 8715-8722.
Postprandial Hyperinsulinemia Accelerates Growth of
Hepatocellular Carcinoma, Kawata, et al., Gut
2002; 51: 100-104.
Insulin-like Growth Factor -1 Activates Gene Transcription
Programs Strongly Associated with Poor Breast Cancer Prognosis, Chreighton, Casa, Lazard, et al., J Clin
Oncol 2008; 26 (25): 4078-4085.
Insulin, Insulin-like Growth Factors and Colon Cancer: A
Review of the Evidence, Giovannucci, J Nutr
2001; 131 (Suppl. 11): s3109-3120.
Glycemic Index, Glycemic Load, and Cancer Risk: A
Meta-analysis, Gnagnarella, Gandini, La Vecchia, & Maisonneuve, Amer. J. Clin. Nutr. 2008; 87 (6): 1793-1801.
Up-regulation of IGF Binding Protein-1 as an
Anti-carcinogenic Strategy: Relevance to Caloric Restriction, Exercise, and
Insulin Sensitivity, McCarty, Medical Hypotheses 1997; 48 (4): 297-308.
The Insulin-like Growth Factor System as a Treatment Target
in Breast Cancer, Yee, Sem. Oncol. 2002;
29 (3 Suppl 11): 86-95.
Cross-talk Among Estrogen Receptor, Epidermal Growth Factor,
and Insulin-like Growth Factor Signaling in Breast Cancer, Lee, Cui &
Oesterreich, Clin. Cancer Res. 2001; 7 (12 Suppl): 4429s-4435s.
Tyrosine Kinase Signalling in Breast Cancer: Insulin-like
Growth Factors and Their Receptors in Breast Cancer, Zhang & Yee, Breast
Cancer Res. 2000; 2 (3): 170-175.
Insulin-like Growth Factors and Cancer, Furstenberger &
Senn, Lancet Oncol. 2002; 3 (5): 298-302.
Insulin-Like Growth Factor (IGF) Family and Prostate Cancer,
Gennigens, Menetrier-Caux & Droz,
Crit. Rev. Oncol. Hematol. 2006; 58 (2): 124-145.
Activation of Estrogen Receptor-mediated Gene Transcription
by IGF-I in Human Breast Cancer Cells,
Lee, Weng, Jackson & Yee, J. Endocrinol. 1997; 152 (1): 39-47.
Vitamin D Analogue EB1089-induced Prostate Regression is
Associated with Increased Gene Expression of Insulin-like Growth Factor Binding
Proteins, Nickerson T. Huynh H. J.
Endocrinol. 1999; 160 (2): 223-229.
Pharmacological Modulation of IGF Serum Concentrations as a
Therapeutic Approach to Control the Growth of Malignant Breast Tumors, Singer,
Hudelist, Schreiber & Kubista, Drugs Today (Barc). 2003; 39 (2): 115-125.
Inhibition of Insulin-like Growth Factor I Receptor
Signaling by the Vitamin D Analogue EB1089 in MCF-7 Breast Cancer Cells: A Role
for Insulin-like Growth Factor Binding Proteins, Rozen & Pollak, Int. J. Oncol. 1999; 15 (3): 589-594.
Insulin, Insulin-like Growth Factors, Insulin Resistance,
and Neoplasia, Pollack Am. J. Clin.
Nutr. 2007; 86 (3): s820-822.
Insulin-Like Growth Factor-I Axis as a Pathway for Cancer
Chemoprevention, Adhami, Afaq & Mukhtar, Clin. Cancer Res. 2006; 212 (19):
5611-5614.
Role of Sugars in
Human Neutrophilic Phagocytosis, Sanchez, Reeser, Lau, et al., Am. J. Clin.
Nutr. 1973; 26: 1180-1184.
Fructose, insulin Resistance, and Metabolic Dyslipidemia,
Basciano, Federico & Adeli, Nutr. Metab. 2005, 2:5
doi:10.1186/1743-7075-2-5.
Metformin Treatment Exerts Antiinvasive and Antimetastatic
Effects in Human Endometrial Carcinoma Cells, Tan, Adya, Chen, et al., J. Clin. Endocrinol. Metab. 2011; 96 (3):
808-816.
Understanding the Benefit of Metformin Use in Cancer
Treatment, Dowling, Goodwin & Stambolic,
BMC Med. 2011; 9: 33.
C-Peptide, Insulin-like Growth Factor Binding Protein-1,
Glycosylated Hemoglobin, and the Risk of Distal Colorectal Adenoma in Women,
Wei, Ma, Pollak,et al., Cancer
Epidemiol. Biomarkers Prev. 2006; 15 (4): 750-755.
SURGERY
Micrometastases Often Persist in Breast Cancer Patients,
Slade, et al, Int. J. Cancer 2005; 114: 94-100.
Wounding from Biopsy and Breast Cancer Progression, Retsky,
Demichelli & Hrushesky, Lancet 2001; 357 (9261): 1048.
Port-sites Excision for Gallbladder Cancer Incidentally
Found After Laparoscpic Cholecystectomy, Guiliante, Ardito, Velone, et al., Am.
J. Surg. 2006; 191 (1): 114-116.
Primary Tumor Removal Increases Vascular Density in Liver
Metastases, Int. J. Cancer, 2004; 112: 554-559.
Menopausal Status Dependence of the Timing of Breast Cancer
Recurrence After Surgical Removal of the Primary Tumour, Demicheli, et al,
Breast Cancer Res.,2004; 6 (6): 689-696.
A Randomized Clinical Trial of a Brief Hypnosis Intervention
to Control Side-effects in Breast Surgery Patients, Montgomery, Bovbjerg,
Schnur, et al., J. Natl. Cancer Inst. 2007; 99 (17): 1304-1312.
Impact of Psycho-therapeutic Support for Patients with
Gastro-intestinal Cancer Undergoing Surgery: 10-Year Survival Results of a
Randomized Trial, Kuchler, Bestmann, Rappat, et al., J. Clin. Oncol. 2007; 25
(19): 2702-2708.
Needle Track Seeding Following Biopsy of Liver Lesions in
the Diagnosis of Hepatocellular Carcinoma: A
Systematic Review and Meta-analysis, Silva, Hegab, Hyde, et al., Gut
2008; 57 (11): 1592-1596.
Decrease in Circulating Anti-angiogenic Factors (Angiostatin
and Endostatin) After Surgical Removal of Primary Colorectal Carcinoma
Coincides with Increased Metabolic Activity of Liver Metastases, Peeters, de
Geus, Westphal, et al., Surgery 2005; 137 (2): 246-249.
Vascular Density in Colorectal Liver Metastases Increases
After Removal of the Primary Tumor in Human Cancer Patients, Peeters, Westphal,
de Waal, et al., Int. J. Cancer 2004;
112 (4): 554-559.
Outgrowth of Human Liver Metastases After Resection of the
Primary Colorectal Tumor: A Shift in the Balance Between Apoptosis and
Proliferation, Peeters, de Waal, Wobbes, et al., Int. J. Cancer 2006; 119 (6): 1249-1253.
Does Surgery Unfavourably Perturb the "Natural
History" of Early Breast Cancer by Accelerating the Appearance of Distant
Metastases?, Baum, Demicheli, Hrushesky
& Retsky Eur. J. Cancer 2005; 41 (4):
508-515.
The Effects of Surgery on Tumor Growth: A Century of
Investigations, Demicheli, Retsky, Hrushesky , et al., Ann. Oncol. 2008; 19
(11): 1821-1828.
Does Surgery Induce Angiogenesis in Breast Cancer? Indirect
Evidence from Relapse Pattern and Mammography Paradox, Retsky, Demicheli &
Hrushesky, Int. J. Surg. 2005; 3 (3):
179-187.
Surgery for Gastric Cancer Increases Plasma Levels of
Vascular Endothelial Growth Factor and von Willebrand Factor, Ikeda, Furukawa,
Imamura, et al., Gastric Cancer 2002; 5
(3): 137-141.
Major Abdominal Surgery Increases Plasma Levels of Vascular
Endothelial Growth Factor: Open More So Than Minimally Invasive Methods,
Belizon, Balik, Feingold, et al., Ann. Surg. 2006; 244 (5): 792-798.
Altered Plasma Matrix Metalloproteinase-9/Tissue Inhibitor
of Matrix Metalloproteinase-1 Concentration During the Early Postoperative
Period in Patients with Colorectal Cancer,
Kirman, Jain, Cekic, et al., Surg. Endosc. 2006; 20 (3): 482-486. Erratum in: Surg.
Endosc. 2006; 20 (4): 706.
Tumor Dormancy and Surgery-driven Interruption of Dormancy
in Breast Cancer: Learning from Failures, Demicheli, Retsky, Hrushesky &
Baum, Nat. Clin. Pract .Oncol. 2007; 4 (12): 699-710. Review.
Anesthesia, Surgery, and the Immune System, Kotani, Curr.
Opin. Anesthesiol. 1993; 6: 562-568.
Hematogenous Dissemination of Hepatocytes and Tumor Cells
After Surgical Resection of Hepatocellular
Carcinoma: A Quantitative Analysis, Wong, Lau, Leung, et al., Clin.
Cancer Res. 1999; 4021–4027.
Hematogenous Dissemination of Prostatic Epithelial Cells
During Radical Prostatectomy, Eschwege, Dumas, Blanchet, et al., Lancet 1995; 346, 1528–1530.
Perioperative Activation of Disseminated Tumor Cells in Bone
Marrow of Patients with Prostate Cancer, Weckermann, Polzer, Ragg, et al., J. Clin. Oncol. 2009; 27: 1549–1556.
Iatrogenic Displacement of Tumor Cells to the Sentinel Node
after Surgical Excision Biopsy in Primary Breast Cancer, Tvedskov, Jensen,
Kroman & Balslev, San Antonio Breast Cancer Symposium, December 11, 2010;
S5-2.
Endothelial Function is Impaired After a High-Salt Meal in
Healthy Subjects, Dickinson, Clifton & Keogh, Am. J. Clin. Nutr. 2011; 93:
500-505.
VITAMIN C
Vitamin C Deficiency in Cancer Patients, Mayland,Bennett
& Allan, Palliat. Med. 2005; 19: 17-20.
High-Dose Vitamin C Selectively Kills Cancer Cells, Levine,
et al., Proc. Natl. Acad. Sciences USA, 2005; 102: 13604-13609.
High-dose vitamin C Therapy: Renewed Hope or False
Promise?Assouline & Miller, Can. Med. Assoc. J. 2006; 174: 956–957.
Intravenous Ascorbate as a Tumor Cytotoxic Chemotheraeutic
Agent, Riordan, et al., Med. Hypotheses 1995; 44: 207-213.
Prolonged Survival linked to Intravenous Vitamin C Seen in
Three Cancer Patients, Levine, et al, Can. Med. Assoc. J., 2006; 174: 937-942.
Changes of Terminal Cancer Patients’ Health-related Quality
of Life After High Dose Vitamin C Administration, Yeom, Jung & Song, J.
Korean Med Sci 2007; 22 (1): 7-11.
Intravenously Administered Vitamin C as a Cancer Therapy:
Three Cases, Padayatty, Riordan, Hewitt, et al., CMAJ 2006; 174 (7): 937-942.
A Pilot Clinical Study of Continuous Intravenous Ascorbate
in Terminal Cancer Patients, Riordan, Casciari, Gonzalez, et al., P R Health
Sci J 2005; 24 (4): 269-276.
Innovation vs. Quality Control: An ‘Unpublishable’Clinical
Trial of Supplemental Ascorbate in Incurable Cancer, Cameron & Campbell,
Med Hypotheses 1991; 36 (3): 185-189.
Reticulum Cell Sarcoma: Two Complete ‘Spontaneous’
Regressions, in Response to High-dose Ascorbic Acid Therapy. A Report on Subsequent Progress, Campbell, Jack & Cameron, Oncology 1991;
48 (6): 495-497.
Changes of Terminal Cancer Patients’ Health-related Quality
of Life After High Dose Vitamin C Administration, Yeom, Jung & Song, J.
Korean Med Sci 2007; 22 (1): 7-11.
Supplemental Ascorbate in the Supportive Treatment of
Cancer: Prolongation of Survival Times in Terminal Human Cancer, Cameron &
Pauling, Proc. Natl Acad Sci USA 1976;
73 (10): 3685-3689.
Supplemental Ascorbate in the Supportive Treatment of
Cancer: Reevaluation of Prolongation of Survival Tmes in Terminal Human Cancer,
Cameron & Pauling, Proc Natl Acad Sci USA 1978; 75: 4538–4542.
Vitamin C Inhibits p53-induced Replicative Senescence
Through Suppression of ROS Production and p38 MAPK Activity, Kim, Jin, Lee, et
al., Biochem Pharmacol. 2008; 22 (5): 651-655.
Pharmacological Doses of Ascorbate Act as a Pro-oxidant and
Decrease Growth of Aggressive Tumor Xenografts in Mice, Chen, Espey, Sun, et
al., Proc. Natl. Acad. Sci. USA 2008;
1105: 11105-11109.
Pharmacologic Ascorbic Acid Concentrations Selectively Kill
Cancer Cells: Action as a Pro-drug to Deliver Hydrogen Peroxide to Tissues,
Chen, Espey, Krishna, et al., Proc. Natl. Acad. Sci. U S A 2005; 102 (38):
13604-13609.
Vitamin C Pharmacokinetics: Implications for Oral and
Intravenous Use, Padayatty, Sun, Wang, et al., Ann. Intern. Med. 2004; 140 (7):
533-537.
Ascorbate in
Pharmacologic Concentrations Selectively Generates Ascorbate Radical and
Hydrogen Peroxide in Extracellular Fluid in vivo, Chen, Espey, Sun, et al.,
Proc. Natl. Acad. Sci U S A 2007; 104 (21): 8749-8754.
Phase I Clinical Trial of I.V. Ascorbic Acid in Advanced
Malignancy, Hoffer, Levine, Assouline, et al., Ann. Oncol. 2008; [Epub ahead of
print]
Emerging Role of Ascorbic Acid in the Management of Advanced
Breast Carcinoma as a Chemosensitizer, Goel, Agarwal, Mandal, et al., Asian J.
Surg. 1999; 22: 333-336.
In vivo Effect of Ascorbic Acid on Enhancement of Human
Natural Killer Cell Activity, Vojdani
& Ghoneum, Nutr. Res.1993; 13:
753-754.
Enhancement of Human Natural Killer Cytotoxic Activity by
Vitamin C in Pure and Augmented Formulations, Vojdani & Namatalla, J. Nutr.
Environ. Med. 1997; 7 (3): 187-195.
The Orthomolecular Treatment of Cancer II. Clinical Trial of
High-dose Ascorbic Acid Supplements in Advanced Human Cancer, Cameron &
Campbell, Chem. Biol. Interact. 1974; 9:
285–315.
Mega-dose Vitamin C as Therapy for Human Cancer? Borst, Proc Natl Acad Sci USA; 2008; 105:
E95.
Vitamin C and Cancer Revisited, Frei & Lawson, Proc Natl
Acad Sci USA 2008;105: 11037–11038.
The Antioxidant
Ascorbic Acid Mobilizes Nuclear Copper Leading to a Prooxidant Breakage of
Cellular DNA: Implications for Chemotherapeutic Action Against Cancer, Ullah,
Khan, Zubair, et al., Cancer Chemother. Pharmacol. 2010 March 6 [Epub ahead of
print] PMID: 20213077.
Catalytic Therapy of Cancer by Ascorbic Acid Involves Redox
Cycling of Exogenous/Endogenous Copper
Ions and Generation of Reactive Oxygen Species,
Hadi, Ullah, Shamim, Bhatt & Azmi,
Chemotherapy 2010; 56 (4): 280-284.
H(2)O(2)-Mediated Cytotoxicity of Pharmacologic Ascorbate
Concentrations to Neuroblastoma Cells:Potential Role of Lactate and Ferritin,
Deubzer, Mayer, Kuçi et al., Cell Physiol. Biochem. 2010; 25 (6): 767-774.
New Developments and Novel Therapeutic Perspectives for
Vitamin C, Li & Schellhorn, J. Nutr. 2007; 137: 2171-2184.
The Vitamin C: Vitamin K3 System – Enhancers and Inhibitors
of the Anti-Cancer Effect, Lamson, Gu, Plaza, et al., Alt. Med. Rev. 2010;
December – pre-publication.
Sodium Ascorbate Induces Apoptosis in Neuroblastoma Cell
Lines by Interfering with Iron Uptake, Carosio, Zuccari, Orienti, et al., Mol.
Cancer 2007; 6 (1): 55-65.
VITAMIN D
Heterodimeric DNA Binding by the Vitamin D Receptor and
Retinoid X Receptors Is Enhanced by 1,25-Dihydroxyvitamin D3 and Inhibited by
9-cis-Retinoic Acid; Evidence for Allosteric Receptor Interactions, Thompson,
Jurutka, Haussler, et al., J. Biol. Chem. 1998; 273 (14): 8483–8491.
All-trans Retinoic Acid Antagonizes the Action of Calciferol
and Its Active Metabolite, 1,25-Dihydroxycholecalciferol, in Rats, Rohde &
DeLuca, J. Nutr. 2005; 135: 1647–1652.
Vitamin D and Cancer, Ali & Vaidya, J. Cancer Res. Ther.
2007; 3 (4): 225-230.
Vitamin D Signalling Pathways in Cancer: Potential for
Anti-cancer Therapeutics, Deeb, Trump & Johnson, Nat. Rev. Cancer 2007; 7
(9): 684-700.
Induction of Ovarian Cancer Cell Apoptosis by
1,25-dihydroxy-Vitamin D3 Through the Down-regulation of Telomerase, Jiang, Bao
, Li, et al., Biol. Chem. 2004; 279 (51): 53213-53221.
High Vitamin D Levels Linked to Improved Lung Cancer
Survival, Zhou, et al., J. Clin. Oncol.
2007; 25: 479-485.
Vitamin D and Calcium Supplementation Reduces Cancer Risk:
Results of a Randomized Trial, Lappe, et
al., Am. J. Clin. Nutr. 2007; 85 (6): 1586-1591.
Vitamin D Supplementation and Total Mortality: a
Meta-analysis of Randomized Controlled Trials, Autier and Gandini, Arch.
Intern. Med. 2007; 167 (16): 1730-1737.
Do Sunlight and Vitamin D Reduce the Likelihood of Colon
Cancer?, Garland & Garland, Int. J. Epidemiol. 2006; 35 (2): 217-220.
Circulating 25-hydroxy Vitamin D Levels and Survival in
Patients with Colorectal Cancer, Ng, Meyerhardt, Wu, et al., J Clin Oncol 2008; 26 (18): 2937-2939.
Molecular Basis of Potential of Vitamin D to Prevent Cancer,
Ingraham, Bragdon & Nohe, Curr. Med. Res. & Opin. 2008; 241: 139-149.
1{alpha}, 25-Dihydroxyvitamin D3 Potentiates Cisplatin
Anti-tumor Activity by p73 Induction in a Squamous Cell Carcinoma Model, Ma, et
al., Mol. Cancer Ther. 2008; 7 (9): 3047-3055
Association Between Serum 25(OH)D and Death from Prostate
Cancer, Tretli, Hernes, Berg, et al., Br. J. Cancer 2009; 1003: 450-454.
Chemotherapy is Linked to Severe Vitamin D Deficiency in
Patients with Colorectal Cancer, Fakih, Trump, Johnson, et al., Int. J.
Colorectal Dis. 2009; 242: 219-224.
Dairy Products, Calcium, and Vitamin D and Risk of Prostate
Cancer, Chan & Giovannucci, Epidemiol. Rev. 2001; 23 (1): 87-92.
Vitamin D is Associated with Improved Survival in
Early-stage Non-Small Cell Lung Cancer Patients, Zhou, Suk, Liu, et al., Cancer
Epidemiol. Biomarkers Prev. 2005; 14 (10): 2303-2309.
Vitamin D Analogue EB1089-induced Prostate Regression is
Associated with Increased Gene Expression of Insulin-like Growth Factor Binding
Proteins, Nickerson T. Huynh H. J.
Endocrinol. 1999; 160 (2): 223-229.
Inhibition of Insulin-like Growth Factor I Receptor
Signaling by the Vitamin D Analogue EB1089 in MCF-7 Breast Cancer Cells: A Role
for Insulin-like Growth Factor Binding Proteins, Rozen & Pollak, Int. J. Oncol. 1999; 15 (3): 589-594.
A Combined Pretreatment of 1,25-Dihydroxyvitamin D3 and
SodiumValproate Enhances the Damaging Effect of Ionizing Radiation on Prostate
Cancer Cells, Gavrilov Leibovich, Ariad, Lavrenkov & Shany, J. Steroid Biochem. Mol. Biol. 2010 [Epub
ahead of print] PMID: 20214985.
Vitamin D3 Distribution and Status in the Body, Heaney,
Horst, Cullen & Armas, J. Am. Coll. Nutr. 2009; 28 (3): 252-256.
Vitamin D for Cancer Prevention: Global Pespective, Garland,
Gorham, Mohr & Garland, Ann. Epidemiol. 2009; 19 (7): 468-483.
Meta-analysis: Longitudinal Studies of Serum Vitamin D and
Colorectal Cancer Risk, Yin, Grandi, Raum, et al., Aliment. Pharmacol. Ther.
2009; 30 (2): 113-125.
Double-blinded Randomized Study of High-dose Calcitriol Plus
Docetaxol Compared with Placebo Plus Docetaxol in Androgen-indpendent Prostate
Cancer: A Report from the ASCENT Investigators, Beer, Ryan, Venner, et al., J.
Clin. Oncol. 2007; 25 (6): 669-674.
A Phase II Trial of Calcitriol and Naproxen in Recurrent
Prostate Cancer, Srinvias & Feldman, Anticancer Res. 2009; 29 (9):
3605-3610.
Phase II Trial of High-dose Intermittent Calcitriol (1,25
dihydroxyvitamin D3) and Dexamethasone in Androgen-independent Prostate Cancer,
Trump, Potter, Muindi, et al., Cancer 2006; 106 (10): 2136-2142.
Immunomodulatory Effects of Vitamin D: Implications for
GVHD, Rosenblatt, Bissonnette, Ahmad, et al., Bone Marr.Transplant. 2010;45
(9): 1463-1468
Vitamin D Status is Associated with Disease-Free Survival
and Overall Survival Time in Patients with Squamous Cell Carcinoma of the Upper
Aerodigestive Tract, Gugatschka, Kiesler, Obermayer-Pietsch, et al., Eur. Arch.
Otorhinolaryngol. 2011 Jan 8. [Epub ahead of print] PMID: 21221617
Seasonal Variation in Blood Drug Concentrations and a
Potential Relationship to Vitamin D, Lindh, Andersson, Eliasson &
Bjorkhem-Bergman, Drug Metab. Dispos. 2011; Feb. 24 [Epub ahead of Print].
Vitamin D Insufficiency and Prognosis in Non-Hodgkin's
Lymphoma, Drake, Maurer, Link, et al., J. Clin. Oncol. 2010; 28 (27):
4191-4198.
VITAMIN K
The Anticancer Effects of Vitamin K, Lamson & Plaza,
Alt. Med. Rev. 2003; 8 (3): 303-318.
The Mechanisms of Vitamin K2- induced Apoptosis of Myeloma
Cells, Tsujioka, Miura, otsuki, et al.,
Haematologica 2006, 91 (5): 613-619.
Oxidative Stress by Ascorbate (Vit C) / Menadione (K3)
Association Kills K562 Human Chronic Myelogenous Leukemia Cells and Inhibits
its Tumor Growth in Nude Mice, Verrax, Stockis, Tison, et al, Biochem. Pharmacol. 72 (6): 671-680.
Vitamin K2 Inhibits the Growth and Invasiveness of
Hepatocellular Carcinoma Cells Via Protein Kinase A Activation, Otsuka, Kato,
Shao, et al., Hepatology 2004; 40 (1): 243-251.
Phase I Trial of Menadiol Diphosphate (Vitamin K3) in
Advanced Malignancy, Lim, et al., Invest. New Drugs 2005; 23: 235–239.
The Vitamin C:Vitamin K3 System – Enhancers and Inhibitors
of the Anticancer Effect, Lamson, Gu, Plaza, et al., Alt Med. Rev. 2010; 15
(4): 345-351.
Cell Cycle Arrest and Autoschizis in a Human Bladder
Carcinoma Cell Line Following Vitamin C and Vitamin K3 Treatment, Jamison,
Gilloteaux, Nassiri, et al., Biochem. Pharmacol. 2004; 67 (2): 337-351.
Bibliography
The Paleolithic Prescription – A Program of Diet and
Exercise and a Design for Living, Eaton, Shostak, and Konner, 1988.
Dietary Options for Cancer Survivors – A Guide to Research
on Foods, Food Substances, Herbals and Dietary Regimens That Might Influence
Cancer, Weldon, et al, American
Institute for Cancer Research, 2002.
Stopping Cancer Before It Starts – The American Institute
for Cancer Research’s Program for Cancer Prevention, The American Institute for
Cancer Research, 1999.
Guns, Germs and Steel – the Fates of Human Societies, Jared
Diamond, 1997.
Foods That Fight Cancer, Preventing Cancer by Diet, Richard
Beliveau and Denis Gingras, 2007
Cooking with Foods That Fight Cancer, Richard Beliveau and
Denis Gingras, 2007
The Complete Natural Medicine Guide to Breast Cancer – A
Practical Manual for Understanding, Prevention and Care, Sat Dharam Kaur,
ND 2003.
Life Over Cancer, Keith Block, 2009.
Healing the Planet- One Patient at a Time, A Primer in
Environmental Medicine, Jozef Krop, 2000.
Healing with Whole Foods - Asian Traditions and Modern
Nutrition, Paul Pritchard, 2003.
The Whole Life Nutrition Cookbook – Whole foods recipes for
personal and planetary health, 2nd edition, Segersten and Malterre, 2008; Whole
Life Press.
Our Toxic World – A Wake-up Call - Chemicals damage your
body, brain, behaviour and sex, Doris Rapp, 2004.
Toxic Deception - How the chemicals industry manipulates
science, bends the law and endangers your health, Dan Fagin, Marianne Lavelle
The CancerSmart Consumer Guide- How to eliminate toxins from
your home and garden products and how to make healthy choices for your family
and the environment, Labour Environmental Alliance Society, Vancouver, B.C.,
www.leas.ca
Clinical Purification, A Complete Treatment and Reference
Manual, Gina Nick, 2001, Longevity Through Prevention.
Clinical Oncology, American Cancer Society, 2000
Cancer Medicine 7 : Holland,Frei et al., editors, 7th
edition, BC Decker, 2006.
The Biology of Cancer, R. Weinberg, Garland Science, 2007.
Robbins Pathologic Basis of Disease, Sixth edition, R.
Cotran, V. Kumar, & T. Collins, W.B.
Saunders Company
Cancer & Natural Medicine - a Textbook of Basic Science
and Clinical Research, John Boik, 1996, Oregon Medical Press
Natural Compounds in Cancer Therapy – Promising Non-toxic
Anti-tumor Agents from Plants and Other Natural Sources, John Boik, 2001,
Oregon Medical Press.
How to Prevent and Treat Cancer with Natural Medicine,
Murray, Birdsall, Pizzorno & Reilly, Riverhead Books, 2002.
Naturally There’s Hope – A Handbook for the Naturopathic
Care of Cancer Patients,
McKinney, Trafford Press, 2003.
An Alternative Medicine Definitive Guide to Cancer, Diamond,
Cowden & Goldberg, Future Medicine Publishing, 1997.
You Don’t Have to Die, Harry Hoxsey, N.D., 1956, Milestone
Books
The Cancer Industry -Unravelling the Politics, Ralph W.
Moss, 1989, Paragon
A Family Guide - Coping with Chemotherapy Using Homeopathy,
Laura Fenton, 2003, Health Harmony Books.
An Introduction to Integrated Healing - Participants’ guide
to self-care, healthful nutrition, vitamins, supplements, complementary medical
therapies and healing, Center for Integrated Healing, 1998
Third Opinion: An International Directory to Alternative
Therapy Centres for the Treatment and Prevention of Cancer and Other
Degenerative Diseases, Second edition, J. M. Fink, 1992; Avery Publishing
Group.
A Guide to Unconventional Cancer Therapies, Ontario Breast
Cancer Information Exchange Project, 1994
Breast Cancer - What you should know (but may not be told)
about prevention, diagnosis and treatment, Steve Austin, N.D. and Cathy
Hitchcock, M.S.W., 1994, Prima Health Publishing
Breast Cancer - The Complete Guide, Third edition, Yashar
Hirshaut & Peter Pressman, 2000, Bantam Books.
Breast Cancer - A Nutritional Approach, Carlton Fredericks,
Ph.D., 1977, Grosset & Dunlap
Beating Cancer with Nutrition, Patrick Quillan, 1994,
Nutrition times Press.
Secrets to Great Health, Jonn Matsen, N.D., 2001, Prima
Publishing
The Schwarzbein Principle, Diana Schwarzbein, MD, 1999,
Health Communications
A Holistic Approach to Cancer Therapy, Wolfgang Woeppel,
1995, Pascoe
Love, Medicine & Miracles - Lessons learned about
self-healing from a surgeon’s experience with exceptional patients, Bernie. S.
Siegel, M.D., 1986, Harper & Row
Homeopathic Medical Repetory, Robin Murphy, N.D., 1993;
Hahnemann Academy of North America.
The Cancer Epidemic: Shadow of the Conquest of Nature,
Gotthard Booth, 1974, Edwin Mellen Press
Cancer Therapy - the Independent Consumer’s Guide to
Non-toxic Treatment and Prevention, Ralph Moss, Equinox Press.
Healthy Fats For Life - Preventing and treating common
health problems with essential fatty acids, L. Vanderhaege, K. Karst, 2003,
Quarry Health Books
Cancer and Vitamin C, Ewan Cameron & Linus Pauling,
1979, Linus Pauling Institute of Science and Medicine
Cancer as a Turning Point, Lawrence LeShan, 1994, Penguin
Press
Nutritional Management of Cancer Patients, Abby S. Block,
1980, Aspen Publishers
Everyone’s Guide to Cancer Therapy, M. Dollinger, E.
Rosebaum, & G. Cable, 1997, Andrews-McMeel Publishers
The Wheatgrass Book, Ann Wigmore, ‘Doctor of Natural Laws’,
1985, Avery Publishing Group.
Healing Words – The Power of Prayer and the Practice of
Medicine, Larry Dossey 1993.
Head First – The Biology of Hope, Norman Cousins, 1989.
Cancer Principles and Practices, V. DeVita, S. Hellman,&
S. Rosenberg, 1997, Lipincott-Raven
Publishers
Handbook of Cancer Chemotherapy, Roland T. Skeel, 2011,
Lipincott.
Manual of Clinical Oncology, D. Casciato & B. Lowitz,
1991, Little Brown
Primer of Epidemiology, Gary Friedman, 1980, McGraw-Hill
Foundations of Epidemiology, A. Lilienfeld, 1976, Oxford U.
Press
FDA Supplement Warnings - Misleading, Exaggerated or
Unproven, Zoltan Rona, June/July 1998, Health Naturally
Increasing and Improving Research in Complementary and
Alternative Medicine, Carlo Calabrese, 2000, NIH Office of Alternative Medicine.
The Cancer Blackout - A history of denied and suppressed
remedies, Maurice Natenberg, 1959, Regent House.
The Medical Mafia - How to get out of it alive and take back
our health & wealth, Ghislaine Lanctot, 2002
edition, self-published.
Hard to Swallow – The Truth About Food Additives, Sargeant
and Evans, 1995, Alive Books
Fight for Your Health, Byron Richards, 2006, Walter
Publishing.
Cancer - A Healing Crisis - the whole-body approach to
cancer therapy, Jack Tropp, 1980, Exposition Press.
The Healing of Cancer - The cures, the cover-ups and the
solution now, Barry Lynes, 1989, Marcus Books.
The Tao of Medicine, Stephen Fulder, 1982, Destiny Books.
Cancer Treatment with Fu Zheng Pei Ben Principle, Pan
Mingji, et al, 1992, Fujian Science
& Technology Publishing House.
7-Day Detox Miracle
2nd ed.,, Bennett & Barrie , 2001; Three Rivers Press.
Living Downstream: An Ecologist Looks at Cancer and the Environment,
Steingraber, 1997, published by Addison-Wesley.
Dismantling Cancer,
Contreras, Baroso-Arnanda & Kennedy, 2004; Interpacific Press.
